| Code | Description | Claims | Beneficiaries | Total Paid |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
394,463 |
350,714 |
$27.35M |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
15,664 |
1,853 |
$3.66M |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
7,710 |
7,563 |
$688K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
1,159 |
563 |
$480K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
7,518 |
6,902 |
$473K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
1,951 |
1,876 |
$253K |
| 90834 |
Psychotherapy, 45 minutes with patient |
2,538 |
1,587 |
$180K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
979 |
748 |
$177K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,027 |
1,985 |
$151K |
| 36415 |
Collection of venous blood by venipuncture |
64,730 |
57,767 |
$142K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
1,779 |
1,696 |
$119K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,817 |
4,490 |
$108K |
| 64615 |
|
539 |
510 |
$105K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
5,485 |
5,150 |
$88K |
| 97810 |
|
2,488 |
1,089 |
$84K |
| 97811 |
|
2,509 |
1,088 |
$78K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
545 |
434 |
$76K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
558 |
544 |
$74K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
173 |
169 |
$71K |
| 95117 |
|
2,540 |
1,456 |
$57K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
774 |
683 |
$51K |
| 97802 |
|
1,175 |
1,104 |
$47K |
| 20610 |
|
218 |
191 |
$39K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
86 |
84 |
$35K |
| Q3014 |
Telehealth originating site facility fee |
4,693 |
4,077 |
$34K |
| 80053 |
Comprehensive metabolic panel |
7,150 |
6,062 |
$32K |
| 90870 |
|
356 |
114 |
$29K |
| 92060 |
|
2,064 |
2,008 |
$29K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,147 |
3,092 |
$25K |
| 90686 |
|
2,184 |
2,071 |
$24K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
133 |
128 |
$24K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,289 |
2,027 |
$24K |
| 92557 |
|
327 |
316 |
$23K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,644 |
1,551 |
$21K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,400 |
1,061 |
$21K |
| 92567 |
|
2,535 |
2,458 |
$20K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,032 |
898 |
$20K |
| 80061 |
Lipid panel |
1,996 |
1,930 |
$20K |
| 93325 |
|
244 |
239 |
$18K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
92 |
92 |
$18K |
| 76536 |
|
258 |
252 |
$18K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
499 |
486 |
$17K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
208 |
206 |
$17K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,836 |
1,720 |
$17K |
| 97813 |
|
592 |
258 |
$16K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,880 |
2,391 |
$15K |
| 92587 |
|
66 |
66 |
$15K |
| 96116 |
|
144 |
136 |
$14K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
768 |
739 |
$14K |
| 97803 |
|
474 |
463 |
$14K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,978 |
1,747 |
$14K |
| 85027 |
|
6,370 |
5,387 |
$13K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,883 |
2,753 |
$12K |
| 0002A |
|
388 |
384 |
$12K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
146 |
65 |
$12K |
| H2012 |
Behavioral health day treatment, per hour |
221 |
26 |
$12K |
| 93320 |
|
162 |
158 |
$11K |
| 97814 |
|
604 |
258 |
$11K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,123 |
1,764 |
$11K |
| 91320 |
|
151 |
150 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,930 |
3,338 |
$9K |
| 0001A |
|
353 |
340 |
$9K |
| 76830 |
Ultrasound, transvaginal |
94 |
90 |
$9K |
| 87631 |
|
149 |
147 |
$8K |
| 11721 |
|
687 |
648 |
$8K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
323 |
315 |
$8K |
| 96138 |
|
83 |
80 |
$7K |
| 77002 |
|
90 |
79 |
$7K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
233 |
182 |
$7K |
| 0072A |
|
211 |
211 |
$6K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
70 |
67 |
$6K |
| 97602 |
|
69 |
49 |
$6K |
| 62323 |
|
12 |
12 |
$6K |
| 90480 |
|
188 |
184 |
$6K |
| 0004A |
|
274 |
261 |
$6K |
| 0071A |
|
189 |
187 |
$5K |
| 73222 |
|
14 |
12 |
$5K |
| 71271 |
|
55 |
55 |
$5K |
| 0124A |
|
182 |
168 |
$5K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
17 |
16 |
$5K |
| 20611 |
|
15 |
13 |
$4K |
| 76881 |
|
40 |
36 |
$4K |
| 90791 |
Psychiatric diagnostic evaluation |
51 |
49 |
$4K |
| 76770 |
|
51 |
50 |
$4K |
| 99215 |
Prolong outpt/office vis |
783 |
696 |
$4K |
| 96367 |
|
61 |
49 |
$4K |
| 0240U |
|
29 |
28 |
$3K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
997 |
903 |
$3K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
177 |
162 |
$3K |
| 96139 |
|
101 |
80 |
$3K |
| 77066 |
Tomosynthesis, mammo |
39 |
38 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
681 |
414 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
203 |
99 |
$3K |
| 95886 |
|
50 |
43 |
$3K |
| G0378 |
Hospital observation service, per hour |
56 |
52 |
$3K |
| 95908 |
|
12 |
12 |
$2K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
13 |
12 |
$2K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
16 |
13 |
$2K |
| 90677 |
|
17 |
16 |
$2K |
| G0008 |
Administration of influenza virus vaccine |
559 |
538 |
$2K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
59 |
39 |
$2K |
| 87632 |
|
20 |
20 |
$2K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
383 |
356 |
$2K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
26 |
12 |
$2K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
32 |
14 |
$2K |
| 0064A |
|
103 |
100 |
$2K |
| 96132 |
|
12 |
12 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
152 |
149 |
$2K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
30 |
12 |
$2K |
| 96118 |
|
42 |
42 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,529 |
1,925 |
$2K |
| 80076 |
|
300 |
282 |
$2K |
| 95024 |
|
177 |
174 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
15 |
$1K |
| 97166 |
|
14 |
14 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
40 |
20 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,057 |
970 |
$1K |
| 92579 |
|
26 |
26 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,080 |
2,081 |
$1K |
| 92134 |
|
200 |
193 |
$1K |
| 76642 |
|
40 |
39 |
$1K |
| 96415 |
|
15 |
13 |
$1K |
| 86780 |
|
114 |
109 |
$1K |
| 0054A |
|
40 |
40 |
$1K |
| J0475 |
Injection, baclofen, 10 mg |
16 |
13 |
$1K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
60 |
32 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
31 |
28 |
$1K |
| 82962 |
|
460 |
102 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
2,312 |
1,906 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
72 |
66 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
72 |
66 |
$983.80 |
| 84439 |
|
92 |
89 |
$980.23 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
475 |
456 |
$950.98 |
| 85652 |
|
1,147 |
1,074 |
$897.58 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,162 |
927 |
$881.13 |
| 82565 |
|
946 |
859 |
$846.61 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
92 |
83 |
$829.11 |
| 95990 |
|
15 |
12 |
$821.84 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
12 |
12 |
$795.93 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,758 |
2,105 |
$777.79 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
358 |
112 |
$753.22 |
| 51798 |
|
111 |
100 |
$729.67 |
| 29075 |
|
19 |
15 |
$687.23 |
| 77065 |
Tomosynthesis, mammo |
12 |
12 |
$678.91 |
| 76886 |
|
15 |
13 |
$671.72 |
| 71250 |
|
13 |
12 |
$618.26 |
| 81513 |
|
29 |
29 |
$594.78 |
| 84450 |
|
755 |
707 |
$574.57 |
| 85610 |
|
750 |
640 |
$551.35 |
| 96133 |
|
12 |
12 |
$547.06 |
| 82728 |
|
53 |
49 |
$522.14 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,642 |
2,025 |
$521.18 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,055 |
1,689 |
$475.25 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,303 |
1,122 |
$462.04 |
| 86803 |
|
56 |
54 |
$442.09 |
| 96119 |
|
13 |
13 |
$442.04 |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
13 |
13 |
$423.46 |
| 0081A |
|
14 |
14 |
$419.98 |
| 87522 |
Neg quan hep c or qual rna |
82 |
77 |
$404.25 |
| 0011A |
|
89 |
79 |
$370.68 |
| 86706 |
|
40 |
39 |
$327.49 |
| 87510 |
|
95 |
89 |
$308.14 |
| 87340 |
|
52 |
51 |
$288.85 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,441 |
1,215 |
$266.53 |
| 87660 |
|
95 |
89 |
$242.49 |
| 87081 |
|
53 |
52 |
$238.14 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
41 |
16 |
$227.09 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
82 |
62 |
$225.00 |
| 81001 |
|
53 |
51 |
$221.60 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
1,690 |
1,571 |
$205.27 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
28 |
27 |
$196.63 |
| 87480 |
|
95 |
89 |
$190.98 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
21 |
20 |
$188.42 |
| 86140 |
|
156 |
142 |
$187.55 |
| 84466 |
|
28 |
26 |
$175.20 |
| 96121 |
|
41 |
38 |
$174.48 |
| 80164 |
|
17 |
17 |
$169.58 |
| 85018 |
|
63 |
43 |
$166.30 |
| 82248 |
|
211 |
194 |
$155.07 |
| 36416 |
|
189 |
174 |
$122.12 |
| 83735 |
|
95 |
43 |
$116.13 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
185 |
137 |
$108.51 |
| 83655 |
|
12 |
12 |
$105.84 |
| 80069 |
|
14 |
14 |
$92.83 |
| 82140 |
|
40 |
38 |
$89.26 |
| 92133 |
|
12 |
12 |
$85.45 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
38 |
27 |
$83.79 |
| 90688 |
|
17 |
15 |
$76.86 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
26 |
13 |
$74.48 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
27 |
26 |
$72.20 |
| 86364 |
|
24 |
12 |
$70.44 |
| 84703 |
|
19 |
14 |
$63.36 |
| 83540 |
|
28 |
26 |
$59.04 |
| 84460 |
|
60 |
53 |
$53.73 |
| 87481 |
|
29 |
29 |
$53.41 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
29 |
29 |
$53.41 |
| 84132 |
|
35 |
26 |
$44.78 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
214 |
135 |
$35.45 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
17 |
12 |
$34.30 |
| 81003 |
|
54 |
51 |
$31.94 |
| 86762 |
|
12 |
12 |
$21.42 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
251 |
162 |
$12.39 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,550 |
1,386 |
$0.01 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
21 |
13 |
$0.01 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
75 |
42 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
18 |
16 |
$0.00 |
| 90662 |
|
14 |
14 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
12 |
12 |
$0.00 |
| 87634 |
|
23 |
23 |
$0.00 |
| 84100 |
|
17 |
12 |
$0.00 |
| A9270 |
Non-covered item or service |
175 |
24 |
$0.00 |
| 80177 |
|
13 |
12 |
$0.00 |